Screener
CG Oncology CGON Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingCostsAndExpenses.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's total costs & expenses?
- CG Oncology (CGON) reported total costs & expenses of $87.56M in Q2 2026.
- How has CG Oncology's total costs & expenses changed year-over-year?
- CG Oncology's total costs & expenses increased by 79.6% year-over-year, from $48.74M to $87.56M.
- What does total costs & expenses mean?
- This metric aggregates all operating and non-operating costs incurred by the company to support its business activities, including research and development, general administration, and production costs. It provides a comprehensive view of the total capital outflow required to sustain operations and clinical development programs. Investors use this to evaluate the company's overall burn rate and operational efficiency.
Ask your AI about CG Oncology's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude